Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines

Yoshihito Nakagawa, Yukihiro Akao

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Fragile histidine triad (FHIT) gene is involved in the deletions at the 3p14.2 region in various cancers. We investigated the role of Fhit protein in cell growth by examining the signaling pathway affected by Fhit. We used 3 human colon cancer cell lines, SW480, DLD-1 and COLO201, in the study. SW480 cells, in which the expression of Fhit is completely absent, were transfected with pIRES1neo vector (SW/IRES cells), wild-type FHIT vector (SW/FHIT cells) or mt-FHIT (codon 96, His changed to Asn) vector (SW/mt-FHIT cells). The growth of SW/FHIT or SW/mt-FHIT cells was suppressed in comparison with that of parent or SW/IRES cells. Especially, the growth of SW/FHIT cells was considerably suppressed. On the other hand, the silencing of FHIT by an siRNA for it in SW/FHIT or DLD-1 cells harboring Fhit demonstrated that the growth of FHIT siRNA-treated cells was significantly enhanced in comparison with that of the vector control or nonspecific siRNA control. Thus, we found that Fhit negatively contributed to cell growth in the colon cancer cell lines. Moreover, SW/FHIT cells exhibited a higher sensitivity to oxidative stress evoked by inhibitors of mitochondrial electron transport or proteasomes compared with any of the control transfectants. The base line amount of phospho-IκB-α (p-IκB-α) was reduced in SW/FHIT cells compared with that in the other transfectants. On the contrary, the FHIT siRNA-treated SW/FHIT and DLD-1 cells exhibited an elevated p-IκB-α level in an RNAi experiment on FHIT. Perturbation of nuclear factor (NF)-κB signaling was strongly suggested by the fact that the wild-type Fhit expressants of SW480 cells tended to be sensitive to sulfasarazine or parthenolide, which are inhibitors of NF-κB. The time course of the level of IκB kinase (IKK) complex (IKKα/β, phospho-IKKα/β and IKKγ) after the treatment with TNF-α was similar between the transfectants. Although p-IκB-α and phospho-NF-κB p65 (p-NF-κB) in SW/FHIT cells responded to TNF-α as those in other transfectants, the increase in the levels of p-IκB-α and p-NF-κB after a 5-min treatment was less in SW/FHIT cells than in the other transfectants. These results altogether suggest that Fhit functions as an anti-oncoprotein by inhibiting the phosphorylation of IκB-α and thereby blocking NF-κB signaling.

Original languageEnglish
Pages (from-to)2433-2442
Number of pages10
JournalExperimental Cell Research
Volume312
Issue number13
DOIs
Publication statusPublished - 01-08-2006

Fingerprint

Histidine
Colonic Neoplasms
Cell Line
Growth
Proteins
Small Interfering RNA
Oncogene Proteins
Proteasome Endopeptidase Complex
Electron Transport
RNA Interference
Codon

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

@article{f8b004a4ffb74323b8b3f649301748fc,
title = "Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines",
abstract = "Fragile histidine triad (FHIT) gene is involved in the deletions at the 3p14.2 region in various cancers. We investigated the role of Fhit protein in cell growth by examining the signaling pathway affected by Fhit. We used 3 human colon cancer cell lines, SW480, DLD-1 and COLO201, in the study. SW480 cells, in which the expression of Fhit is completely absent, were transfected with pIRES1neo vector (SW/IRES cells), wild-type FHIT vector (SW/FHIT cells) or mt-FHIT (codon 96, His changed to Asn) vector (SW/mt-FHIT cells). The growth of SW/FHIT or SW/mt-FHIT cells was suppressed in comparison with that of parent or SW/IRES cells. Especially, the growth of SW/FHIT cells was considerably suppressed. On the other hand, the silencing of FHIT by an siRNA for it in SW/FHIT or DLD-1 cells harboring Fhit demonstrated that the growth of FHIT siRNA-treated cells was significantly enhanced in comparison with that of the vector control or nonspecific siRNA control. Thus, we found that Fhit negatively contributed to cell growth in the colon cancer cell lines. Moreover, SW/FHIT cells exhibited a higher sensitivity to oxidative stress evoked by inhibitors of mitochondrial electron transport or proteasomes compared with any of the control transfectants. The base line amount of phospho-IκB-α (p-IκB-α) was reduced in SW/FHIT cells compared with that in the other transfectants. On the contrary, the FHIT siRNA-treated SW/FHIT and DLD-1 cells exhibited an elevated p-IκB-α level in an RNAi experiment on FHIT. Perturbation of nuclear factor (NF)-κB signaling was strongly suggested by the fact that the wild-type Fhit expressants of SW480 cells tended to be sensitive to sulfasarazine or parthenolide, which are inhibitors of NF-κB. The time course of the level of IκB kinase (IKK) complex (IKKα/β, phospho-IKKα/β and IKKγ) after the treatment with TNF-α was similar between the transfectants. Although p-IκB-α and phospho-NF-κB p65 (p-NF-κB) in SW/FHIT cells responded to TNF-α as those in other transfectants, the increase in the levels of p-IκB-α and p-NF-κB after a 5-min treatment was less in SW/FHIT cells than in the other transfectants. These results altogether suggest that Fhit functions as an anti-oncoprotein by inhibiting the phosphorylation of IκB-α and thereby blocking NF-κB signaling.",
author = "Yoshihito Nakagawa and Yukihiro Akao",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.yexcr.2006.04.004",
language = "English",
volume = "312",
pages = "2433--2442",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "13",

}

Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines. / Nakagawa, Yoshihito; Akao, Yukihiro.

In: Experimental Cell Research, Vol. 312, No. 13, 01.08.2006, p. 2433-2442.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines

AU - Nakagawa, Yoshihito

AU - Akao, Yukihiro

PY - 2006/8/1

Y1 - 2006/8/1

N2 - Fragile histidine triad (FHIT) gene is involved in the deletions at the 3p14.2 region in various cancers. We investigated the role of Fhit protein in cell growth by examining the signaling pathway affected by Fhit. We used 3 human colon cancer cell lines, SW480, DLD-1 and COLO201, in the study. SW480 cells, in which the expression of Fhit is completely absent, were transfected with pIRES1neo vector (SW/IRES cells), wild-type FHIT vector (SW/FHIT cells) or mt-FHIT (codon 96, His changed to Asn) vector (SW/mt-FHIT cells). The growth of SW/FHIT or SW/mt-FHIT cells was suppressed in comparison with that of parent or SW/IRES cells. Especially, the growth of SW/FHIT cells was considerably suppressed. On the other hand, the silencing of FHIT by an siRNA for it in SW/FHIT or DLD-1 cells harboring Fhit demonstrated that the growth of FHIT siRNA-treated cells was significantly enhanced in comparison with that of the vector control or nonspecific siRNA control. Thus, we found that Fhit negatively contributed to cell growth in the colon cancer cell lines. Moreover, SW/FHIT cells exhibited a higher sensitivity to oxidative stress evoked by inhibitors of mitochondrial electron transport or proteasomes compared with any of the control transfectants. The base line amount of phospho-IκB-α (p-IκB-α) was reduced in SW/FHIT cells compared with that in the other transfectants. On the contrary, the FHIT siRNA-treated SW/FHIT and DLD-1 cells exhibited an elevated p-IκB-α level in an RNAi experiment on FHIT. Perturbation of nuclear factor (NF)-κB signaling was strongly suggested by the fact that the wild-type Fhit expressants of SW480 cells tended to be sensitive to sulfasarazine or parthenolide, which are inhibitors of NF-κB. The time course of the level of IκB kinase (IKK) complex (IKKα/β, phospho-IKKα/β and IKKγ) after the treatment with TNF-α was similar between the transfectants. Although p-IκB-α and phospho-NF-κB p65 (p-NF-κB) in SW/FHIT cells responded to TNF-α as those in other transfectants, the increase in the levels of p-IκB-α and p-NF-κB after a 5-min treatment was less in SW/FHIT cells than in the other transfectants. These results altogether suggest that Fhit functions as an anti-oncoprotein by inhibiting the phosphorylation of IκB-α and thereby blocking NF-κB signaling.

AB - Fragile histidine triad (FHIT) gene is involved in the deletions at the 3p14.2 region in various cancers. We investigated the role of Fhit protein in cell growth by examining the signaling pathway affected by Fhit. We used 3 human colon cancer cell lines, SW480, DLD-1 and COLO201, in the study. SW480 cells, in which the expression of Fhit is completely absent, were transfected with pIRES1neo vector (SW/IRES cells), wild-type FHIT vector (SW/FHIT cells) or mt-FHIT (codon 96, His changed to Asn) vector (SW/mt-FHIT cells). The growth of SW/FHIT or SW/mt-FHIT cells was suppressed in comparison with that of parent or SW/IRES cells. Especially, the growth of SW/FHIT cells was considerably suppressed. On the other hand, the silencing of FHIT by an siRNA for it in SW/FHIT or DLD-1 cells harboring Fhit demonstrated that the growth of FHIT siRNA-treated cells was significantly enhanced in comparison with that of the vector control or nonspecific siRNA control. Thus, we found that Fhit negatively contributed to cell growth in the colon cancer cell lines. Moreover, SW/FHIT cells exhibited a higher sensitivity to oxidative stress evoked by inhibitors of mitochondrial electron transport or proteasomes compared with any of the control transfectants. The base line amount of phospho-IκB-α (p-IκB-α) was reduced in SW/FHIT cells compared with that in the other transfectants. On the contrary, the FHIT siRNA-treated SW/FHIT and DLD-1 cells exhibited an elevated p-IκB-α level in an RNAi experiment on FHIT. Perturbation of nuclear factor (NF)-κB signaling was strongly suggested by the fact that the wild-type Fhit expressants of SW480 cells tended to be sensitive to sulfasarazine or parthenolide, which are inhibitors of NF-κB. The time course of the level of IκB kinase (IKK) complex (IKKα/β, phospho-IKKα/β and IKKγ) after the treatment with TNF-α was similar between the transfectants. Although p-IκB-α and phospho-NF-κB p65 (p-NF-κB) in SW/FHIT cells responded to TNF-α as those in other transfectants, the increase in the levels of p-IκB-α and p-NF-κB after a 5-min treatment was less in SW/FHIT cells than in the other transfectants. These results altogether suggest that Fhit functions as an anti-oncoprotein by inhibiting the phosphorylation of IκB-α and thereby blocking NF-κB signaling.

UR - http://www.scopus.com/inward/record.url?scp=33745869448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745869448&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2006.04.004

DO - 10.1016/j.yexcr.2006.04.004

M3 - Article

C2 - 16733051

AN - SCOPUS:33745869448

VL - 312

SP - 2433

EP - 2442

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 13

ER -